We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Brand drugmaker Otsuka America Pharmaceutical has signed an agreement allowing specialty pharma company Prasco Laboratories to launch an authorized generic version of its leg-pain drug Pletal — a launch that precedes outside generic competition on the product.
Flu vaccine maker Aventis-Pasteur said yesterday it would produce 2.6 million additional doses this year, the latest move to offset a massive U.S. flu vaccine shortage.
A trade association consisting of some of the largest Canadian mail-order pharmacies has adopted a position opposing “commercial fulfillments” for Rx drugs from U.S. municipalities and states.
HHS Secretary Tommy Thompson has urged state attorneys general (AGs) to investigate and prosecute any distributor who takes advantage of the influenza vaccine shortage by jacking up prices — advice that several AGs already have followed.
Acknowledging that its inability to meet customer demand for its Cypher drug-eluting stent has been disappointing, Johnson & Johnson said last week that Cypher inventory is expected to start increasing this month, enabling the company to fill existing back-orders.
Pfizer has launched a prescription drug plan that allows millions of uninsured patients in the U.S. to purchase company products at significant discounts.
Although voters have expressed outrage at the high cost of prescription drugs, pharmaceutical issues are not likely to determine the outcome of the presidential election, according to political observers and polls.
Overall reported political giving by the pharmaceutical and health products industries is down by more than one-half in the 2004 election compared with the last two election cycles — a trend that reflects new campaign finance laws and, perhaps, a lull in the battle after winning a hard-fought Medicare drug benefit.
The U.S. biopharmaceutical industry is projected to add more than 122,000 jobs over the next decade, with states that have existing pharmaceutical clusters expected to gain the most, according to a new study.
President Bush has indicated he is open to the possibility of importing drugs from Canada if such a plan could be proven safe, but Democratic presidential candidate Sen. John Kerry (D-Mass.) countered the president has blocked legislation that would do just that.